Gastrointestinal Pharmacology III Flashcards
What strategies are utilized by antidiarrheals?
- thicken stool and reduce intestinal smooth muscle contraction
- treat symptoms
- should be avoided in infection-caused acute diarrhea
- can mask symptoms and delay the treatment of infection
What opioids are used as antidiarrheals?
mechanism of action?
clinical uses?
Adverse effects?
drug-drug interactions?
- drugs
- Loperamide (diamode)
- diphenoxylate
- mechanism of action
- stimulate opiate receptors (micro and delta) on enteric neurons and inhibiting presynaptic cholinergic action
- suppress smooth muscle contraction
- enhance mucosal absorption
- decrease gastrocolic reflex
- stimulate opiate receptors (micro and delta) on enteric neurons and inhibiting presynaptic cholinergic action
- metabolism
- substrate of CYP2C8, CYP3A4, and pg-protein
- Clinical uses
- treate travelers diarrhea and chronic diarrhea
- Loperamide: nonprescription drug
- High dose: arrhythmia
- Diphenoxylate: prescription drug
- higher dose: central nervous effects
- long-term use: dependence
- commercial preparations: combined with atropine (lomotil) to prevent overdose
- Loperamide: nonprescription drug
- treate travelers diarrhea and chronic diarrhea
- Adverse effects
- constipation and dry mouth (b/c decrease effects ACh)
- Drug-drug interactions
- loperamide with inhibitors of CYP3A4, 2C8, and pg-protein
- some patients will take high dose of loperamide to achieve euphoria & take inhibitors of CYP3A4, 2C8, and pg-protein, purposefully reducing the metabolism & achieve euphoric effects
- will results in arrhythmia
- some patients will take high dose of loperamide to achieve euphoria & take inhibitors of CYP3A4, 2C8, and pg-protein, purposefully reducing the metabolism & achieve euphoric effects
- loperamide with inhibitors of CYP3A4, 2C8, and pg-protein
What type of drugs are Kaolin & Pectin?
Mechanism of Action?
Clinical use?
additional considerations?
- Adsorbents
- Kaolin: hydrated magnesium aluminum silicate
- Pectin: indigestible carbohydrates
- Mechanism of Action
- adsorbents of bacteria, toxin, and fluid
- Clinical use
- often administered to kids to treat acute diarrhea
- Additional considerations
- should be taken within 2 hours of other drugs
What type of drug is bismuth subsalicylate?
Mechanism of Action?
Use?
- Adsorbents
- mechanism of action: not clear
- salicylate: reduce chloride secretion
- bismuth: binds to bacteria and enterotoxin
- clinical use
- prevent and treat traveler’s diarrhea
- short term
What type of drug is bile salt-binding resins
Mechanism of Action?
Use?
- Adsorbent
- colestipol: colestid
- cholestyramine: loCHOLEST
- Mechanism of Action
- bind to bile
- Clinical use
- reat bile malabsorption-caused diarrhea
What is the synthetic somatostatin drug?
Mechanism of Action?
Adminstration?
- Octreotide (sandostatin)
- Mechanism of Action
- Inhibit secretion of 5-HT, gastrin, glucagon, growth hormone, insulin, secretin, pancreatic polypeptide, VIP, cholecytokinin, adn pituitary hormones
- reduce fluid secretion
- slow GI motility and inhibits gallbladder contraction
- Route: IV, subQ, or IM
Clinical uses of octreotide?
- Synthetic somatostatin
- Clinical uses
- treat secretory diarrhea caused by endocrine tumor (carcinoid, VIPoma)
- high dose (100-250 micrograms): treat diarrhea caused by vagotomy or dumping dyndrome, short bowel syndrom or AIDS
- treat pancretic fistula
- treat pituitary tumors
- Adverse effects
- lipid-soluble vitamin deficiency
- gallstones
- nausea, abdominal pain, flatulence, and diarrhea
- hyper- and hypo-glycemia
- hypothyroidism, bradycardia
What is the Tryptophan hydroxylase inhibitor drug?
Mechanism of Action
Clinical use?
Adverse effects?
- Drug: telotristat ethyl (Xermelo)
- Mechanism of Action
- Inhibit the enzyme that converts L-tryptophan to 5-hydroxy-tryptophan (tryptophan hydroxylase)
- leads to a subsequent decrease in seratonin
- Inhibit the enzyme that converts L-tryptophan to 5-hydroxy-tryptophan (tryptophan hydroxylase)
- Clinical use
- combined witha somatostatin analogue
- carcinoid syndrome diarrhea that is not adequately controlled by a somatostatin analogue alone
- combined witha somatostatin analogue
- Adverse effects
- most common
- nausea, headache, depression, flatulence, decreased appetite, peripheral edema, fever, adn liver enzyme elvations
- large dose: constipation
- most common

What is the name of the chloride channel inhibitor?
Mechanism of action?
clinical uses?
Adverse effects?
- crofelemer
- Mechanism of Action
- inhibit the secretion of chloride ions into the intestine
- Clinical uses
- antiretroviral-induced diarrhea
- provide symptom relief
- Adverse effects
- upper respiratory infection
- flatulence
- and increased bilirubin
Identify the location of receptors for antemetic drugs
- Chemoreceptor trigger zone
- CNS
- Vestibular system
- Pharynx
- Vagal adn spinal afferent nerves in GI
- Chemoreceptor trigger zone
- D2
- NK1
- 5-HT3
- CNS
- H1
- M1
- NK1
- 5-HT3
- Vestibular system
- M1
- H1
- Pharynx
- M1
- Vagal and spinal afferent nerves in GI
- 5-HT3

What drug classes are used to prevent and treat nausea and vomiting?
- antagonists for
- NK1
- 5-HT3
- D2
- M1
- H1
- others
- benzodiazepines
- CB1 agonists
What are the causes of emesis?
- Chemotherapy
- Acute (24 hrs, 5-HT3)
- delayed (48 hrs to several days, neurokinin)
- anticipatory
- motion sickness
- others
- non-chemotherapy drug-induced emesis
- infections
- PONV (postoperative nausea and vomiting)
- Radiation
- Pregnancy
- Disease
What are the 5-HT3 antagonists?
mechanism of action?
clinical uses?
Adverse effects?
- Drugs (-setrond)
- ondabsetron
- dolasetron
- grabisetron
- palonosetron
- Mechanism of action
- blocking both central and perioheral 5-HT3 receptors
- Clinical uses
- 5-HT3 antagonist + dexamethasone (corticosteroid)
- the most effective therapy for prevention of chemotherapy-induced acute severe vomiting
- prevent and treat acute emesis caused by radiation and postoperation
- 5-HT3 antagonist + dexamethasone (corticosteroid)
- Adverse effects
- headache
- constipation
- dizziness
- prolonged QT intercal (antibiotics?)
What are the NK1-antagonists?
mechanism of action?
clinical uses?
Adverse effects?
- drugs (-pitants)
- Aprepitant (Emend)
- fosaprepitant
- rolapitant (Varubi)
- MOA
- blocking central NK1 receptors
- Clinical uses
- NK1 antagonists + dexamethasome
- prevent delayed emesis caused by chemotherapy
- NK1 antagonists + 5-HT3 antagonists + dexamethasone
- prevent acute adn delayed emesis caused by chemotherapy
- NK1 antagonists + dexamethasome
- Adverse Effects
- all drugs are the substrates of CYP3A4, interact wth CYP3A4 inducers and inhibitors
- Rolapitant: also a substrate of p-gp, interacts with p-gp inhibitors adn inducers
- Cmmon adverse effects: hiccups, decreased appetite, and dizziness
- Rolapitant also causes neutropenia and allergic reactions
What are the benzodiazepines?
Mechanisms of Action?
Clinical use?
- Drugs
- Lorazepam (Ativan)
- diazepam
- Mechanisms of Action
- enhance GABA’s effect on chloride ion conductance leading to sedation, hypnosis, anesthesia, etc.
- Clnical uses
- prevent anticipatory nausea and vomiting prior to the initiation of chemotherapy
What are the synthetic cannabinoids?
Mechanism of action?
clinical use?
Adverse effects?
- Drugs
- Dronabinol (marinol schedule III)
- Nabilone (cesamet: schedule II)
- Mechanism of action
- stimulate CB1 adn block 5-HT3 receptor in vomiting center
- Clinical uses
- chemotherapy-induced emesis
- reserved for patients who are intolerant or refractory to first-line therapy
- combined with phenothiazines
- provides synergistic antiemetic action
- chemotherapy-induced emesis
- Adverse effects
- cannabinoids-like effects
What drugs are used to treat motion sickness?
- M1 receptor antagonists
- scopolamine transdermal patch
- one of the best agents for prevention of motion sickness
- H1 receptor antagonists
- MOAs and uses
- meclizine (antivert): block H1 receptors, motion sickness and vertigo
- diphenhydramine and doxylamine: block both H1 and M1 receptors
- MOAs and uses
What drugs are used to treat morning sickness?
- doxylamine + pyridoxine:
- who dont’ resond to conservative management
- diphenhydramine + other antiemetics
- chemotherapy-induced vomiting
What are the D2 dopamine receptors antagonist antiemetic drugs?
Mecanisms of action?
Clinical uses?
Adverse effects?
- Drugs
- Antipsychotics
- phenothiazine (prochlorperazine)
- butyrophenonones (droperidol)
- substituted benzamides
- metoclopramide
- Antipsychotics
- Mechanism of Action
- phenothiazine
- block central D, M and H1 receptors
- Butyrophenones and substituted benzamides
- block central D2 receptors
- phenothiazine
- Clinical uses
- Phenotiazines: general emesis
- Butyrophenones: postoperative and anticipatory nausea and vomiting
- Substituted benzamides (high dose): treat radiation, chemotherapy, and infection-induced nausea and vomiting
- Adverse effects
- apply to all: extrapyramidal effects
- droperidol and metoclopramide: prolonged QT interval
What drugs are used to treat diarrhea-predominant irritable bowel syndrome?
- Opioid receptor agonist
- loperamide
- eluxadoline
- micro -opioid receptor agonist and delta-opioid receptor antagonist
- micro receptor stimulation: decrease muscle contractilty, inhibit water and electrolyte seretion
- delta receptor blocking: reduce the risk of constipation and pain
- contraindication: patients without a gallbladder — serous pancreatitis
- a lof ot drug-drug interactions
- micro -opioid receptor agonist and delta-opioid receptor antagonist
- bile acid sequestrants
- 5-HT3 receptor antagonists (Alosetron)
- approved for women with severe IBS with diarrhea predominant
- Antibiotic: rifamixin
- MOA
- alter gut microbiota and may reduce mucosal inflammation adn visceral hypersensitivity
- use
- refractory IBD, relieve bloating, abdominal pain, stool frequency
- drug interaction
- interact with inhibitors or inducers of p-gp
- MOA
What drugs are used to treat constipation-predominant IBS?
- Fiber-rich laxatives
- stool softeners
- osmotic laxatives
- chloide channer activator
- lubiprostone, approved for women with IBS in whom constipation is predominant
- Guanylate cyclase type-C agonists (linaclotide, plecanatide)
What are the guanylate cyclase type-C agonist drugs?
Mechanism of action?
Clinical uses?
Adverse effects?
Contraindication?
- Drugs
- linaclotide
- Plecanatide
- Mechanism of Action
- can activate guanylcyclase-type C (GC-C) receptors
- increasing the cGMP levels
- increase levels of intestinal fluid
- and decrease gastrointestinal transit time
- increase frequency of bowel movement
- increasing the cGMP levels
- increase extracellular cGMP levels
- activity of pain-sensing nerves decreases
- indestinal pain decreases
- activity of pain-sensing nerves decreases
- can activate guanylcyclase-type C (GC-C) receptors
- Clinical uses
- chronic idopathic constipation
- IBS with constipation dominant
- Adverse effects
- diarrhea, abdominal pain and distention, and flatulence
- Contraindication
- patients <6
- mechanical GI obstruction
What is the partial neuronal 5-HT4 agonist?
Mechanism of action?
Clinical uses?
Adverse efects?
Contraindications?
- tegaserod
- mechanism of action
- activates 5-HT4 receptors
- activate seratonin receptors increase the release of ACh release
- leads to GI motility
- also activates 5-HT1B and 5-HT2A – coronary artery and intracranial artery spasm
- activates 5-HT4 receptors
- clinical uses
- severe IBS-C in women younger than age 65 ith no history of CV ischeic diseases
- Adverse effects
- headache, abdominal pain, diarrhea, serious cardiovascular events (MI, Stroke, angina)
- Contraindications
- history of MI, stroke, TIA, or angina

What drugs are used to abdominal pain?
Mehcniasm of action?
Adverse effects?
Contraindications?
- drugs
- low dose of antidepressants
- selective serotonin reuptake inhibitors (SSRI, fluoxetine)
- tricyclic antidepressants (TCA, amitriptyline)
- anticholinergics (antispasmodics) dicyclomine and hyoscyamine
- low dose of antidepressants
- Mechanism of action
- can increase endorphin release
- decrease norepinephrine reuptake
- decrease serotonin uptake
- therefore inhibit pain pathways
- GI adverse effects
- SSRI: diarrhea
- TCA adn anticholinergics: constipation
- Contraindication
- SSRI: diarrhea
- TCA adn anticholinergics: constipation


- Anticipatory nausea and vomiting
- Lorazepam (benzodiazepine)

- delayed nausea and vomiting (increased release NK1)
- acute is more associated w/ seratonin
- B - combinaiton of ondansetron, aprepitant and dexamethasone
List the drugs used to treat peptic ulcer
- H+/K+-ATPase inhibitors
- H2 antagonists
- antacids
- mucosal defenders
- antibiotics (H. pylori infection)
list the drugs used to treat IBD
- 5-ASAs
- oral corticosteroids
- immunomodulators
- biologis
List the drugs that increase GI motility
- D2 antagonists
- AChE inhibitor
- laxatives
- bulk-forming
- stool softener
- lubricant
- chloride channel activator
- osmotic laxatives
- stimulant laxatives
- opioid receptor antagonists
- 5-HT4 receptor agonist
list the drugs that decrease GI motility
- antidiarrheals
- opiates
- adsorbents
- synthetic somatostatin
- chloride channel inhibitor
- antiemetics
- 5-HT3, NK1, M1, D2, and H1 antagonists
- benzodiazepines
- synthetic cannabinoids
List the drugs used to treat IBS
- Diarrheal
- opioid receptor agonists
- 5-HT3 antagoinst
- constipation
- laxatives
- GC-C receptor agonist
- 5-HT4 agonist
- Pain
- SSRI
- TCA
- anticholinergic agents